HERTFORDSHIRE, England and PITTSBURGH, Feb. 14, 2017 /PRNewswire/ -- Mylan N.V. (NASDAQ, TASE: MYL) today applauds the rebranding of the Generic Pharmaceutical Association (GPhA) to the Association for Accessible Medicines (AAM).
Mylan CEO Heather Bresch commented, "The launch of GPhA's new brand – the Association for Accessible Medicines – reflects what we mean to America's healthcare system. Today, generic medicines are used to fill nearly 90% of prescriptions in the U.S., yet represent only 27% of the cost. The new name also reflects the dramatic shift in how healthcare is being delivered in our country, and the increasing importance for patients approaching the pharmacy counter to experience the true savings that our medicines provide."
Visit accessiblemeds.org to learn more.
Mylan is a global pharmaceutical company committed to setting new standards in healthcare. Working together around the world to provide 7 billion people access to high quality medicine, we innovate to satisfy unmet needs; make reliability and service excellence a habit; do what's right, not what's easy; and impact the future through passionate global leadership. We offer a growing portfolio of more than 2,700 generic and branded pharmaceuticals, including antiretroviral therapies on which approximately 50% of people being treated for HIV/AIDS in the developing world depend. We market our products in more than 165 countries and territories. Our global R&D and manufacturing platform includes more than 50 facilities, and we are one of the world's largest producers of active pharmaceutical ingredients. Every member of our more than 35,000-strong workforce is dedicated to creating better health for a better world, one person at a time. Learn more at mylan.com.
SOURCE Mylan N.V.